- Home
- GANX vs STEM Comparison
GANX vs STEM Comparison
Compare GANX & STEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GANX | STEM |
|---|---|---|
| Founded | 2017 | 2009 |
| Country | United States | United States |
| Employees | 21 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.2M | 75.3M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | GANX | STEM |
|---|---|---|
| Price | $1.85 | $9.42 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 3 |
| Target Price | $7.50 | ★ $13.33 |
| AVG Volume (30 Days) | ★ 677.3K | 103.3K |
| Earning Date | 05-13-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.46 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $55,180.00 | ★ $156,266,000.00 |
| Revenue This Year | N/A | $3.43 |
| Revenue Next Year | N/A | $13.92 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 8.08 |
| 52 Week Low | $1.41 | $0.29 |
| 52 Week High | $4.34 | $32.23 |
Technical Indicators
Market Signals| Indicator | GANX | STEM |
|---|---|---|
| Relative Strength Index (RSI) | 42.70 | 46.09 |
| Support Level | $1.55 | $8.12 |
| Resistance Level | $2.03 | $10.99 |
| Average True Range (ATR) | 0.14 | 0.69 |
| MACD | -0.00 | 0.16 |
| Stochastic Oscillator | 41.43 | 51.57 |
Price Performance
Historical ComparisonAbout GANX Gain Therapeutics Inc.
Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.
About STEM Stem Inc.
Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on technology services that transform the way energy is distributed and consumed.